SCHEMBL8006760

SCHEMBL8006760

CCCC[C@H](N)C(O)C(=O)NC1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.51
METAP2 P50579 2/20 0.48
EPHX1 P07099 11/20 0.44
EPHX2 P34913 2/20 0.43
METAP1 P53582 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8492486 1.00 SIGMAR1 (0.51) SIGMAR1METAP2EPHX1EPHX2METAP1
SCHEMBL12829172 0.98 SIGMAR1 (0.53) SIGMAR1METAP2EPHX1EPHX2
SCHEMBL6876305 0.94 METAP1 (0.49) SIGMAR1METAP2EPHX1METAP1
SCHEMBL6876886 0.94 METAP1 (0.49) SIGMAR1METAP2EPHX1METAP1
SCHEMBL6875880 0.94 METAP1 (0.49) SIGMAR1METAP2EPHX1METAP1
SCHEMBL3411145 0.94 METAP1 (0.49) SIGMAR1METAP2EPHX1METAP1
Hydrochloric Acid SCHEMBL742741 0.92 METAP1 (0.48) SIGMAR1METAP2EPHX1METAP1
Hydrochloric Acid SCHEMBL742742 0.92 METAP1 (0.48) SIGMAR1METAP2EPHX1METAP1
SCHEMBL8491681 0.91 SMN1; SMN2 (0.46) SIGMAR1METAP2EPHX1EPHX2
SCHEMBL13338123 0.88 SMN1; SMN2 (0.42) SIGMAR1METAP2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 EP disclosed
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 EP disclosed
EP-1008592-B1 Cyclic amide derivatives which inhibit cathepsin K SEIKAGAKU KOGYO CO LTD (JP) 2006-02-01 EP disclosed
US-6117870-A USEFUL AS THERAPEUTIC DRUG OR PREVENTIVE DRUG OF ARTHRITIS AND RHEUMATISM DUE TO INCREASE OF BONE RESORPTION IN ADDITION TO BONE DISEASES SUCH AS OSTEOPOROSIS, HYPERCALCEMIA, AND PAGET'S DISEASE FUJIREBIO KABUSHIKI KAISHA (JP) 2000-09-12 US disclosed